Articles from CTT Pharmaceutical Holdings, Inc.

TAMPA, FL / ACCESS Newswire / June 22, 2026 / CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) has signed an LOI with a testing company in the United States to conduct clinical trials and testing for several potential nicotine products for CTT Pharma. A partnership with this company would allow CTT the ability to independently go to market in the United States utilizing our patented technology. CTT Pharma will notify shareholders as more information becomes available.

TAMPA, FL / ACCESS Newswire / June 17, 2026 / CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) has signed an LOI with a company in the United States to conduct clinical trials and testing for several potential nicotine products for CTT Pharma. A partnership with this company would allow CTT the ability to independently go to market in the United States utilizing our patented technology. CTT Pharma will notify shareholders as more information becomes available.

Company Advancing Licensing and Partnership Negotiations Patent Applications Accepted in Australia and Jamaica - Grants Anticipated Shortly HAMILTON, ON / ACCESSWIRE / June 15, 2021 / CTT Pharmaceutical Holdings, Inc., (the "Company" or "CTT") (OTC PINK:CTTH), an innovative life sciences company with a portfolio of IP in novel drug delivery systems, announced today that Canadian law firm Gowlings WLC confirmed that CTT's Canadian patent